Literature DB >> 11448080

Cerebral blood flow and metabolic abnormalities in Alzheimer's disease.

H Matsuda1.   

Abstract

In this review I summarize observations of PET and SPECT studies about cerebral blood flow and metabolic abnormalities in Alzheimer's disease. In very early AD flow or metabolism reduces first in the posterior cingulate gyrus and precuneus. This reduction may arise from functional deafferentation caused by primary neural degeneration in the remote area of the entorhinal cortex that is the first to be pathologically affected in AD. Then medial temporal structures and parietotemporal association cortex show flow or metabolic reduction as disease processes. The reason why flow or metabolism in medial temporal structures shows delay in starting to reduce in spite of the earliest pathological affection remains to be elucidated. It is likely that anterior cingulate gyrus is functionally involved, since attention is the first non-memory domain to be affected, before deficits in language and visuospatial functions. However few reports have described involvement in the anterior cingulate gyrus. Relationship between cerebral blood flow or metabolism and apolipoprotein E genotype has been investigated. Especially, the APOE epsilon4 allele has been reported to increase risk and to lower onset age as a function of the inherited dose of the epsilon4 allele. Reduction of flow or metabolism in the posterior cingulate gyrus and precuneus has been reported even in presymptomatic nondemented subjects who were cognitively normal and had at least a single epsilon4 allele. On the contrary the relation of epsilon4 allele to the progression rate of AD has been controversial from neuroimaging approaches. PET and SPECT imaging has become to be quite useful for assessing therapeutical effects of newly introduced treatment for AD. Recent investigations observed significant regional flow increase after donepezil hydrochloride treatment. Most of these observations have been made by applying computer assisted analysis of three-dimensional stereotactic surface projection or statistical parametric mapping instead of a conventional regions of interest technique.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448080     DOI: 10.1007/BF02988596

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  66 in total

1.  Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry.

Authors:  G B Frisoni; C Testa; A Zorzan; F Sabattoli; A Beltramello; H Soininen; M P Laakso
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer's Disease.

Authors:  Wenna Duan; Parshant Sehrawat; Arvind Balachandrasekaran; Ashish B Bhumkar; Paresh B Boraste; James T Becker; Lewis H Kuller; Oscar L Lopez; H Michael Gach; Weiying Dai
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 3.  A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile.

Authors:  Konstantine K Zakzanis; Simon J Graham; Zachariah Campbell
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

Review 4.  Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.

Authors:  Siddhartha Mondragón-Rodríguez; Gustavo Basurto-Islas; Hyoung-gon Lee; George Perry; Xiongwei Zhu; Rudy J Castellani; Mark A Smith
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

5.  The cerebral response during subjective choice with and without self-reference.

Authors:  Sterling C Johnson; Taylor W Schmitz; Tisha N Kawahara-Baccus; Howard A Rowley; Andrew L Alexander; Jonghoon Lee; Richard J Davidson
Journal:  J Cogn Neurosci       Date:  2005-12       Impact factor: 3.225

6.  Whole brain analysis of T2* weighted baseline FMRI signal in dementia.

Authors:  Serge A R B Rombouts; Philip Scheltens; Joost P A Kuijer; Frederik Barkhof
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

7.  Inter-modality relationship constrained multi-modality multi-task feature selection for Alzheimer's Disease and mild cognitive impairment identification.

Authors:  Feng Liu; Chong-Yaw Wee; Huafu Chen; Dinggang Shen
Journal:  Neuroimage       Date:  2013-09-14       Impact factor: 6.556

8.  Reproducibility of brain MRS in older healthy adults at 7T.

Authors:  S Andrea Wijtenburg; Laura M Rowland; Georg Oeltzschner; Peter B Barker; Clifford I Workman; Gwenn S Smith
Journal:  NMR Biomed       Date:  2018-11-29       Impact factor: 4.044

Review 9.  Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.

Authors:  Christina E Wierenga; Mark W Bondi
Journal:  Neuropsychol Rev       Date:  2007-05-03       Impact factor: 7.444

10.  Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI.

Authors:  Michael D Greicius; Gaurav Srivastava; Allan L Reiss; Vinod Menon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.